Sign in

CIK 0000879407

  • Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
460408024
Phone
+1 626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 4 Grant or award Director acquired 7,500 shares (grant or award)
  2. 4 Grant or award Director acquired 8,000 shares (grant or award)
  3. 4 Grant or award Director acquired 7,500 shares (grant or award)
  4. 4 Grant or award Chief Operating Officer acquired 250,000 shares (grant or award)
  5. 4 Grant or award General Counsel acquired 70,000 shares (grant or award)
  6. 4 Grant or award Chief Executive Officer acquired 900,000 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 85,000 shares (grant or award)
  8. 4 Grant or award Director acquired 7,500 shares (grant or award)
  9. 4 Grant or award Director acquired 8,000 shares (grant or award)
  10. 4 Open-market sale Chief Executive Officer sold 83,333 shares at $63.50 ($5,291,646)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale Chief Executive Officer sold 183,333 shares at an average $67.15 ($12,310,119)
  13. 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $67.33 ($3,366,522)
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Option exercise Chief Financial Officer acquired 12,649 shares (option exercise)
  17. 4 Open-market sale Chief Financial Officer sold 37,884 shares at an average $40.85 ($1,547,378)
  18. 4 Open-market sale Chief Executive Officer sold 56,325 shares at $31.83 ($1,792,825)
  19. 4 Open-market sale Chief Executive Officer sold 20,000 shares at $28.25 ($565,000)
  20. 4 Open-market sale Chief Executive Officer sold 112,650 shares at an average $28.54 ($3,215,055)

Page 11 of 25 · 497 filings